{"denoms":[{"counts":[{"groupId":"BG000","value":"550"},{"groupId":"BG001","value":"546"},{"groupId":"BG002","value":"1096"}],"units":"Participants"}],"groups":[{"description":"Nivolumab 3 mg/kg combined with Ipilimumab 1 mg/kg solutions intravenously every 3 weeks for 4 doses then Nivolumab 3 mg/kg solutions intravenously every 2 weeks until documented disease progression, discontinuation due to toxicity, withdrawal of consent or the study ends","id":"BG000","title":"Nivolumab + Ipilimumab"},{"description":"Sunitinib 50 mg capsules by mouth once daily for 4 weeks then 2 weeks off, continuously until documented disease progression, discontinuation due to toxicity, withdrawal of consent or the study ends After completion of final analysis eligible participants may switch from receiving Sunitinib to receiving Nivolumab 3 mg/kg IV combined with Ipilimumab 1 mg/kg IV every 3 weeks for 4 doses then Nivolumab 240mg flat dose IV every 2 weeks","id":"BG001","title":"Sunitinib"},{"description":"Total of all reporting groups","id":"BG002","title":"Total"}],"measures":[{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","spread":"9.76","value":"61.1"},{"groupId":"BG001","spread":"10.10","value":"60.7"},{"groupId":"BG002","spread":"9.93","value":"60.9"}]}]}],"dispersionType":"STANDARD_DEVIATION","paramType":"MEAN","populationDescription":"All Randomized","title":"Age, Continuous","unitOfMeasure":"Years"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"137"},{"groupId":"BG001","value":"151"},{"groupId":"BG002","value":"288"}],"title":"Female"},{"measurements":[{"groupId":"BG000","value":"413"},{"groupId":"BG001","value":"395"},{"groupId":"BG002","value":"808"}],"title":"Male"}]}],"paramType":"COUNT_OF_PARTICIPANTS","populationDescription":"All Randomized Participants","title":"Sex: Female, Male","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"12"},{"groupId":"BG001","value":"17"},{"groupId":"BG002","value":"29"}],"title":"Hispanic or Latino"},{"measurements":[{"groupId":"BG000","value":"264"},{"groupId":"BG001","value":"253"},{"groupId":"BG002","value":"517"}],"title":"Not Hispanic or Latino"},{"measurements":[{"groupId":"BG000","value":"274"},{"groupId":"BG001","value":"276"},{"groupId":"BG002","value":"550"}],"title":"Unknown or Not Reported"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Ethnicity (NIH/OMB)","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"486"},{"groupId":"BG001","value":"483"},{"groupId":"BG002","value":"969"}],"title":"White"},{"measurements":[{"groupId":"BG000","value":"7"},{"groupId":"BG001","value":"6"},{"groupId":"BG002","value":"13"}],"title":"Black or African American"},{"measurements":[{"groupId":"BG000","value":"46"},{"groupId":"BG001","value":"47"},{"groupId":"BG002","value":"93"}],"title":"Asian"},{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"}],"title":"American Indian or Alaska Native"},{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"}],"title":"Native Hawaiian or Pacific Islander"},{"measurements":[{"groupId":"BG000","value":"10"},{"groupId":"BG001","value":"10"},{"groupId":"BG002","value":"20"}],"title":"Other"},{"measurements":[{"groupId":"BG000","value":"1"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"1"}],"title":"Not Reported"}]}],"paramType":"COUNT_OF_PARTICIPANTS","populationDescription":"All Randomized Participants","title":"Race/Ethnicity, Customized","unitOfMeasure":"Participants"}],"populationDescription":"All Randomized Participants"}